GRAIL, Inc. (GRAL)
(Delayed Data from NSDQ)
$41.65 USD
+2.06 (5.20%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $41.66 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
GRAIL, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GRAL 41.65 +2.06(5.20%)
Will GRAL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GRAL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GRAL
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
GRAL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates
Stock Market News for May 23, 2025
QuidelOrtho Unveils Results Manager System to Streamline Testing
Other News for GRAL
Pocket Pivot appears for GRAL after 5.2% move
GRAL forms NR7 on September 19
Technical picture remains unchanged for GRAL after it falls 1.2% on September 18
GRAIL Inc Signs New Headquarters Lease Agreement
GRAL forms NR7 on September 16